Is ELUX B undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6
Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of ELUX B when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: ELUX B (SEK84.42) is trading below our estimate of fair value (SEK276.88)
Significantly Below Fair Value: ELUX B is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for ELUX B?
Key metric: As ELUX B is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.
The above table shows the Price to Sales ratio for ELUX B. This is calculated by dividing ELUX B's market cap by their current
revenue.
What is ELUX B's PS Ratio?
PS Ratio
0.2x
Sales
SEK 133.82b
Market Cap
SEK 23.44b
ELUX B key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Sales vs Industry: ELUX B is good value based on its Price-To-Sales Ratio (0.2x) compared to the European Consumer Durables industry average (0.7x).
Price to Sales Ratio vs Fair Ratio
What is ELUX B's PS Ratio
compared to its
Fair PS Ratio?
This is the expected PS Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
ELUX B PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio
0.2x
Fair PS Ratio
0.8x
Price-To-Sales vs Fair Ratio: ELUX B is good value based on its Price-To-Sales Ratio (0.2x) compared to the estimated Fair Price-To-Sales Ratio (0.8x).
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst ELUX B forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
SEK 84.42
SEK 111.22
+31.7%
17.0%
SEK 140.00
SEK 80.00
n/a
9
Nov ’25
SEK 89.12
SEK 112.33
+26.0%
18.0%
SEK 140.00
SEK 80.00
n/a
9
Oct ’25
SEK 98.32
SEK 112.44
+14.4%
17.2%
SEK 140.00
SEK 87.00
n/a
9
Sep ’25
SEK 98.68
SEK 111.78
+13.3%
17.9%
SEK 140.00
SEK 83.00
n/a
9
Aug ’25
SEK 91.92
SEK 111.78
+21.6%
17.9%
SEK 140.00
SEK 83.00
n/a
9
Jul ’25
SEK 87.52
SEK 114.78
+31.1%
18.5%
SEK 140.00
SEK 80.00
n/a
9
Jun ’25
SEK 99.78
SEK 114.78
+15.0%
18.5%
SEK 140.00
SEK 80.00
n/a
9
May ’25
SEK 97.32
SEK 114.78
+17.9%
18.5%
SEK 140.00
SEK 80.00
n/a
9
Apr ’25
SEK 95.62
SEK 114.22
+19.5%
24.4%
SEK 165.00
SEK 76.00
n/a
9
Mar ’25
SEK 90.68
SEK 114.22
+26.0%
24.4%
SEK 165.00
SEK 76.00
n/a
9
Feb ’25
SEK 97.46
SEK 125.73
+29.0%
23.6%
SEK 180.00
SEK 85.00
n/a
11
Jan ’25
SEK 108.10
SEK 131.40
+21.6%
20.7%
SEK 180.00
SEK 90.00
n/a
10
Dec ’24
SEK 103.95
SEK 130.50
+25.5%
21.8%
SEK 180.00
SEK 85.00
n/a
10
Nov ’24
SEK 94.72
SEK 136.50
+44.1%
17.9%
SEK 180.00
SEK 96.00
SEK 89.12
10
Oct ’24
SEK 113.05
SEK 150.90
+33.5%
16.2%
SEK 190.00
SEK 113.00
SEK 98.32
10
Sep ’24
SEK 118.45
SEK 153.55
+29.6%
17.7%
SEK 190.00
SEK 110.00
SEK 98.68
11
Aug ’24
SEK 128.45
SEK 155.36
+21.0%
18.2%
SEK 190.00
SEK 110.00
SEK 91.92
11
Jul ’24
SEK 147.20
SEK 162.00
+10.1%
19.8%
SEK 207.00
SEK 100.00
SEK 87.52
11
Jun ’24
SEK 143.70
SEK 162.00
+12.7%
19.8%
SEK 207.00
SEK 100.00
SEK 99.78
11
May ’24
SEK 154.55
SEK 157.91
+2.2%
21.5%
SEK 207.00
SEK 100.00
SEK 97.32
11
Apr ’24
SEK 125.92
SEK 152.45
+21.1%
20.6%
SEK 207.00
SEK 100.00
SEK 95.62
11
Mar ’24
SEK 125.20
SEK 149.70
+19.6%
21.2%
SEK 207.00
SEK 100.00
SEK 90.68
10
Feb ’24
SEK 147.28
SEK 163.10
+10.7%
17.6%
SEK 207.00
SEK 110.00
SEK 97.46
10
Jan ’24
SEK 140.78
SEK 155.60
+10.5%
19.8%
SEK 207.00
SEK 110.00
SEK 108.10
10
Dec ’23
SEK 150.90
SEK 155.60
+3.1%
19.8%
SEK 207.00
SEK 110.00
SEK 103.95
10
Nov ’23
SEK 132.42
SEK 156.10
+17.9%
22.9%
SEK 215.00
SEK 110.00
SEK 94.72
10
Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.